APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artemisinin Derivatives Market Analysis and Forecast 2026-2032

27 December 2025213 pages

Choose your research edition.

Industry ResearchArtemisinin Derivatives Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin Derivatives Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Artemisinin Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin Derivatives Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin Derivatives Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Artemisinin Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Artemisinin Derivatives's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Kerui Nanhai Pharmaceutical as the global sales leader, a title it has maintained for several consecutive years. Notably, Kerui Nanhai Pharmaceutical's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.

The major global manufacturers in the Artemisinin Derivatives market include Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Shanghai Natural Bio-engineering, Sanofi, Kunming Pharmaceutical, Kerui Nanhai, Guilin Pharmaceutical, Guangxi Xiancaotang Pharmaceutical and Guangxi Xiancaotang, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Artemisinin Derivatives production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Artemisinin Derivatives by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Artemisinin Derivatives, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artemisinin Derivatives, also provides the consumption of main regions and countries. Of the upcoming market potential for Artemisinin Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artemisinin Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artemisinin Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Artemisinin Derivatives sales, projected growth trends, production technology, application and end-user industry.

Artemisinin Derivatives Segment by Company

Kerui Nanhai Pharmaceutical

Shanghai Natural Bio-engineering Co

Shanghai Natural Bio-engineering

Sanofi

Kunming Pharmaceutical

Kerui Nanhai

Guilin Pharmaceutical

Guangxi Xiancaotang Pharmaceutical

Guangxi Xiancaotang

Novanat Bioresource

KPC Pharmaceuticals

Botanical Extracts EPZ Ltd

ArtemiFlow

Artemisinin Derivatives Segment by Type

Dihydroartemisinin

Artemisunate

Others

Artemisinin Derivatives Segment by Application

Malaria Treatment

Scientific Research

Others

Artemisinin Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Artemisinin Derivatives production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Artemisinin Derivatives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Artemisinin Derivatives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artemisinin Derivatives sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artemisinin Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dihydroartemisinin Major Manufacturers Table 3. Artemisunate Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Artemisinin Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Malaria Treatment Major Manufacturers Table 7. Scientific Research Major Manufacturers Table 8. Others Major Manufacturers Table 9. Artemisinin Derivatives Industry Trends Table 10. Artemisinin Derivatives Industry Drivers Table 11. Artemisinin Derivatives Industry Opportunities and Challenges Table 12. Artemisinin Derivatives Industry Restraints Table 13. Global Artemisinin Derivatives Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 14. Global Artemisinin Derivatives Production by Region (2021-2026) & (t) Table 15. Global Artemisinin Derivatives Production by Region (2027-2032) & (t) Table 16. Global Artemisinin Derivatives Production Market Share by Region (2021-2026) Table 17. Global Artemisinin Derivatives Production Market Share by Region (2027-2032) Table 18. Global Artemisinin Derivatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Artemisinin Derivatives Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Artemisinin Derivatives Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Artemisinin Derivatives Revenue Market Share by Region (2021-2026) Table 22. Global Artemisinin Derivatives Revenue Market Share by Region (2027-2032) Table 23. Global Artemisinin Derivatives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 24. Global Artemisinin Derivatives Sales by Region (2021-2026) & (t) Table 25. Global Artemisinin Derivatives Sales by Region (2027-2032) & (t) Table 26. Global Artemisinin Derivatives Sales Market Share by Region (2021-2026) Table 27. Global Artemisinin Derivatives Sales Market Share by Region (2027-2032) Table 28. Global Artemisinin Derivatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Artemisinin Derivatives Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Artemisinin Derivatives Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Artemisinin Derivatives Sales Market Share by Manufacturers (2021-2026) Table 32. Global Artemisinin Derivatives Sales Price (USD/t) of Manufacturers (2021-2026) Table 33. Global Artemisinin Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Artemisinin Derivatives Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Artemisinin Derivatives Manufacturers, Product Type & Application Table 36. Global Artemisinin Derivatives Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Artemisinin Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Artemisinin Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Artemisinin Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Artemisinin Derivatives Revenue Market Share by Type (2021-2026) Table 42. Global Artemisinin Derivatives Revenue Market Share by Type (2027-2032) Table 43. Global Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 44. Global Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 45. Global Artemisinin Derivatives Sales Market Share by Type (2021-2026) Table 46. Global Artemisinin Derivatives Sales Market Share by Type (2027-2032) Table 47. Global Artemisinin Derivatives Price by Type (2021-2026) & (USD/t) Table 48. Global Artemisinin Derivatives Price by Type (2027-2032) & (USD/t) Table 49. Global Artemisinin Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Artemisinin Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Artemisinin Derivatives Revenue Market Share by Application (2021-2026) Table 52. Global Artemisinin Derivatives Revenue Market Share by Application (2027-2032) Table 53. Global Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 54. Global Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 55. Global Artemisinin Derivatives Sales Market Share by Application (2021-2026) Table 56. Global Artemisinin Derivatives Sales Market Share by Application (2027-2032) Table 57. Global Artemisinin Derivatives Price by Application (2021-2026) & (USD/t) Table 58. Global Artemisinin Derivatives Price by Application (2027-2032) & (USD/t) Table 59. Kerui Nanhai Pharmaceutical Company Information Table 60. Kerui Nanhai Pharmaceutical Business Overview Table 61. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 62. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio Table 63. Kerui Nanhai Pharmaceutical Recent Development Table 64. Shanghai Natural Bio-engineering Co Company Information Table 65. Shanghai Natural Bio-engineering Co Business Overview Table 66. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio Table 68. Shanghai Natural Bio-engineering Co Recent Development Table 69. Shanghai Natural Bio-engineering Company Information Table 70. Shanghai Natural Bio-engineering Business Overview Table 71. Shanghai Natural Bio-engineering Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio Table 73. Shanghai Natural Bio-engineering Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Sanofi Artemisinin Derivatives Product Portfolio Table 78. Sanofi Recent Development Table 79. Kunming Pharmaceutical Company Information Table 80. Kunming Pharmaceutical Business Overview Table 81. Kunming Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio Table 83. Kunming Pharmaceutical Recent Development Table 84. Kerui Nanhai Company Information Table 85. Kerui Nanhai Business Overview Table 86. Kerui Nanhai Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Kerui Nanhai Artemisinin Derivatives Product Portfolio Table 88. Kerui Nanhai Recent Development Table 89. Guilin Pharmaceutical Company Information Table 90. Guilin Pharmaceutical Business Overview Table 91. Guilin Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio Table 93. Guilin Pharmaceutical Recent Development Table 94. Guangxi Xiancaotang Pharmaceutical Company Information Table 95. Guangxi Xiancaotang Pharmaceutical Business Overview Table 96. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio Table 98. Guangxi Xiancaotang Pharmaceutical Recent Development Table 99. Guangxi Xiancaotang Company Information Table 100. Guangxi Xiancaotang Business Overview Table 101. Guangxi Xiancaotang Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio Table 103. Guangxi Xiancaotang Recent Development Table 104. Novanat Bioresource Company Information Table 105. Novanat Bioresource Business Overview Table 106. Novanat Bioresource Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Novanat Bioresource Artemisinin Derivatives Product Portfolio Table 108. Novanat Bioresource Recent Development Table 109. KPC Pharmaceuticals Company Information Table 110. KPC Pharmaceuticals Business Overview Table 111. KPC Pharmaceuticals Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio Table 113. KPC Pharmaceuticals Recent Development Table 114. Botanical Extracts EPZ Ltd Company Information Table 115. Botanical Extracts EPZ Ltd Business Overview Table 116. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio Table 118. Botanical Extracts EPZ Ltd Recent Development Table 119. ArtemiFlow Company Information Table 120. ArtemiFlow Business Overview Table 121. ArtemiFlow Artemisinin Derivatives Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. ArtemiFlow Artemisinin Derivatives Product Portfolio Table 123. ArtemiFlow Recent Development Table 124. North America Artemisinin Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Artemisinin Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 127. North America Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 128. North America Artemisinin Derivatives Sales Price by Type (2021-2026) & (USD/t) Table 129. North America Artemisinin Derivatives Sales Price by Type (2027-2032) & (USD/t) Table 130. North America Artemisinin Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Artemisinin Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 133. North America Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 134. North America Artemisinin Derivatives Sales Price by Application (2021-2026) & (USD/t) Table 135. North America Artemisinin Derivatives Sales Price by Application (2027-2032) & (USD/t) Table 136. North America Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Artemisinin Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Artemisinin Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032) & (t) Table 140. North America Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 141. North America Artemisinin Derivatives Sales by Country (2027-2032) & (t) Table 142. North America Artemisinin Derivatives Sales Price by Country (2021-2026) & (USD/t) Table 143. North America Artemisinin Derivatives Sales Price by Country (2027-2032) & (USD/t) Table 144. United States Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 145. Canada Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 146. Mexico Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 147. Europe Artemisinin Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Artemisinin Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 150. Europe Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 151. Europe Artemisinin Derivatives Sales Price by Type (2021-2026) & (USD/t) Table 152. Europe Artemisinin Derivatives Sales Price by Type (2027-2032) & (USD/t) Table 153. Europe Artemisinin Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 154. Europe Artemisinin Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 155. Europe Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 156. Europe Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 157. Europe Artemisinin Derivatives Sales Price by Application (2021-2026) & (USD/t) Table 158. Europe Artemisinin Derivatives Sales Price by Application (2027-2032) & (USD/t) Table 159. Europe Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Europe Artemisinin Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Europe Artemisinin Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Europe Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032) & (t) Table 163. Europe Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 164. Europe Artemisinin Derivatives Sales by Country (2027-2032) & (t) Table 165. Europe Artemisinin Derivatives Sales Price by Country (2021-2026) & (USD/t) Table 166. Europe Artemisinin Derivatives Sales Price by Country (2027-2032) & (USD/t) Table 167. Germany Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 168. France Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 169. U.K. Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 170. Italy Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 171. Russia Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 172. Spain Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 173. Netherlands Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 174. Switzerland Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 175. Sweden Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 176. Poland Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 177. China Artemisinin Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 178. China Artemisinin Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 179. China Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 180. China Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 181. China Artemisinin Derivatives Sales Price by Type (2021-2026) & (USD/t) Table 182. China Artemisinin Derivatives Sales Price by Type (2027-2032) & (USD/t) Table 183. China Artemisinin Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 184. China Artemisinin Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 185. China Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 186. China Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 187. China Artemisinin Derivatives Sales Price by Application (2021-2026) & (USD/t) Table 188. China Artemisinin Derivatives Sales Price by Application (2027-2032) & (USD/t) Table 189. Asia Artemisinin Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 190. Asia Artemisinin Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 191. Asia Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 192. Asia Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 193. Asia Artemisinin Derivatives Sales Price by Type (2021-2026) & (USD/t) Table 194. Asia Artemisinin Derivatives Sales Price by Type (2027-2032) & (USD/t) Table 195. Asia Artemisinin Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 196. Asia Artemisinin Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 197. Asia Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 198. Asia Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 199. Asia Artemisinin Derivatives Sales Price by Application (2021-2026) & (USD/t) Table 200. Asia Artemisinin Derivatives Sales Price by Application (2027-2032) & (USD/t) Table 201. Asia Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Asia Artemisinin Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Asia Artemisinin Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Asia Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032) & (t) Table 205. Asia Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 206. Asia Artemisinin Derivatives Sales by Country (2027-2032) & (t) Table 207. Asia Artemisinin Derivatives Sales Price by Country (2021-2026) & (USD/t) Table 208. Asia Artemisinin Derivatives Sales Price by Country (2027-2032) & (USD/t) Table 209. Japan Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 210. South Korea Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 211. India Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 212. Australia Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 213. Taiwan Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 214. Southeast Asia Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 215. SAMEA Artemisinin Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA Artemisinin Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA Artemisinin Derivatives Sales by Type (2021-2026) & (t) Table 218. SAMEA Artemisinin Derivatives Sales by Type (2027-2032) & (t) Table 219. SAMEA Artemisinin Derivatives Sales Price by Type (2021-2026) & (USD/t) Table 220. SAMEA Artemisinin Derivatives Sales Price by Type (2027-2032) & (USD/t) Table 221. SAMEA Artemisinin Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 222. SAMEA Artemisinin Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 223. SAMEA Artemisinin Derivatives Sales by Application (2021-2026) & (t) Table 224. SAMEA Artemisinin Derivatives Sales by Application (2027-2032) & (t) Table 225. SAMEA Artemisinin Derivatives Sales Price by Application (2021-2026) & (USD/t) Table 226. SAMEA Artemisinin Derivatives Sales Price by Application (2027-2032) & (USD/t) Table 227. SAMEA Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. SAMEA Artemisinin Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. SAMEA Artemisinin Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. SAMEA Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032) & (t) Table 231. SAMEA Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 232. SAMEA Artemisinin Derivatives Sales by Country (2027-2032) & (t) Table 233. SAMEA Artemisinin Derivatives Sales Price by Country (2021-2026) & (USD/t) Table 234. SAMEA Artemisinin Derivatives Sales Price by Country (2027-2032) & (USD/t) Table 235. Brazil Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 236. Argentina Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 237. Chile Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 238. Colombia Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 239. Peru Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 240. Saudi Arabia Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 241. Israel Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 242. UAE Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 243. Turkey Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 244. Iran Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 245. Egypt Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Artemisinin Derivatives Distributors List Table 249. Artemisinin Derivatives Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Artemisinin Derivatives Product Image Figure 2. Global Artemisinin Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure . Dihydroartemisinin Image Figure 1. Artemisunate Image Figure 2. Others Image Figure 3. Global Artemisinin Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Artemisinin Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure 5. Malaria Treatment Image Figure 6. Scientific Research Image Figure 7. Others Image Figure 8. Global Artemisinin Derivatives Capacity, Capacity Utilization (2021-2032) & (t) Figure 9. Global Artemisinin Derivatives Production by Region: 2021 VS 2025 VS 2032 (t) Figure 10. Global Artemisinin Derivatives Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Artemisinin Derivatives Production Market Share by Region (2021-2032) Figure 12. North America Artemisinin Derivatives Production Growth Rate (2021-2032) & (t) Figure 13. Europe Artemisinin Derivatives Production Growth Rate (2021-2032) & (t) Figure 14. China Artemisinin Derivatives Production Growth Rate (2021-2032) & (t) Figure 15. Japan Artemisinin Derivatives Production Growth Rate (2021-2032) & (t) Figure 16. Global Artemisinin Derivatives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Artemisinin Derivatives Revenue (2021-2032) & (US$ Million) Figure 18. Global Artemisinin Derivatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Artemisinin Derivatives Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Artemisinin Derivatives Revenue Market Share by Region (2021-2032) Figure 21. Global Artemisinin Derivatives Sales (2021-2032) & (t) Figure 22. Global Artemisinin Derivatives Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 23. Global Artemisinin Derivatives Sales Market Share by Region (2021-2032) Figure 24. North America Artemisinin Derivatives Sales YoY (2021-2032) & (t) Figure 25. Europe Artemisinin Derivatives Sales YoY (2021-2032) & (t) Figure 26. China Artemisinin Derivatives Sales YoY (2021-2032) & (t) Figure 27. Asia (Excluding China) Artemisinin Derivatives Sales YoY (2021-2032) & (t) Figure 28. South America, Middle East and Africa Artemisinin Derivatives Sales YoY (2021-2032) & (t) Figure 29. Global Artemisinin Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Artemisinin Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Artemisinin Derivatives Revenue Market Share by Type (2021-2032) Figure 33. Global Artemisinin Derivatives Sales Market Share by Type (2021-2032) Figure 34. Global Artemisinin Derivatives Revenue Market Share by Application (2021-2032) Figure 35. Global Artemisinin Derivatives Sales Market Share by Application (2021-2032) Figure 36. North America Artemisinin Derivatives Revenue Share by Type (2021-2032) Figure 37. North America Artemisinin Derivatives Sales Share by Type (2021-2032) Figure 38. North America Artemisinin Derivatives Revenue Share by Application (2021-2032) Figure 39. North America Artemisinin Derivatives Sales Share by Application (2021-2032) Figure 40. North America Artemisinin Derivatives Revenue Share by Country (2021-2032) Figure 41. North America Artemisinin Derivatives Sales Share by Country (2021-2032) Figure 42. Europe Artemisinin Derivatives Revenue Share by Type (2021-2032) Figure 43. Europe Artemisinin Derivatives Sales Share by Type (2021-2032) Figure 44. Europe Artemisinin Derivatives Revenue Share by Application (2021-2032) Figure 45. Europe Artemisinin Derivatives Sales Share by Application (2021-2032) Figure 46. Europe Artemisinin Derivatives Revenue Share by Country (2021-2032) Figure 47. Europe Artemisinin Derivatives Sales Share by Country (2021-2032) Figure 48. China Artemisinin Derivatives Revenue Share by Type (2021-2032) Figure 49. China Artemisinin Derivatives Sales Share by Type (2021-2032) Figure 50. China Artemisinin Derivatives Revenue Share by Application (2021-2032) Figure 51. China Artemisinin Derivatives Sales Share by Application (2021-2032) Figure 52. Asia Artemisinin Derivatives Revenue Share by Type (2021-2032) Figure 53. Asia Artemisinin Derivatives Sales Share by Type (2021-2032) Figure 54. Asia Artemisinin Derivatives Revenue Share by Application (2021-2032) Figure 55. Asia Artemisinin Derivatives Sales Share by Application (2021-2032) Figure 56. Asia Artemisinin Derivatives Revenue Share by Country (2021-2032) Figure 57. Asia Artemisinin Derivatives Sales Share by Country (2021-2032) Figure 58. SAMEA Artemisinin Derivatives Revenue Share by Type (2021-2032) Figure 59. SAMEA Artemisinin Derivatives Sales Share by Type (2021-2032) Figure 60. SAMEA Artemisinin Derivatives Revenue Share by Application (2021-2032) Figure 61. SAMEA Artemisinin Derivatives Sales Share by Application (2021-2032) Figure 62. SAMEA Artemisinin Derivatives Revenue Share by Country (2021-2032) Figure 63. SAMEA Artemisinin Derivatives Sales Share by Country (2021-2032) Figure 64. Artemisinin Derivatives Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Artemisinin Derivatives Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Dihydroartemisinin
  • Artemisunate
  • Others
Applications
  • Malaria Treatment
  • Scientific Research
  • Others
Companies covered
  • Kerui Nanhai Pharmaceutical
  • Shanghai Natural Bio-engineering Co
  • Shanghai Natural Bio-engineering
  • Sanofi
  • Kunming Pharmaceutical
  • Kerui Nanhai
  • Guilin Pharmaceutical
  • Guangxi Xiancaotang Pharmaceutical
  • Guangxi Xiancaotang
  • Novanat Bioresource
  • KPC Pharmaceuticals
  • Botanical Extracts EPZ Ltd
  • ArtemiFlow

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artemisinin Derivatives Market by Type
  3. 1.2.1 Global Artemisinin Derivatives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dihydroartemisinin
  5. 1.2.3 Artemisunate
  6. 1.2.4 Others
  7. 1.3 Artemisinin Derivatives Market by Application
  8. 1.3.1 Global Artemisinin Derivatives Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Malaria Treatment
  10. 1.3.3 Scientific Research
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Artemisinin Derivatives Market Dynamics
  1. 2.1 Artemisinin Derivatives Industry Trends
  2. 2.2 Artemisinin Derivatives Industry Drivers
  3. 2.3 Artemisinin Derivatives Industry Opportunities and Challenges
  4. 2.4 Artemisinin Derivatives Industry Restraints
3 Global Artemisinin Derivatives Production Overview
  1. 3.1 Global Artemisinin Derivatives Production Capacity (2021-2032)
  2. 3.2 Global Artemisinin Derivatives Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Artemisinin Derivatives Production by Region
  4. 3.3.1 Global Artemisinin Derivatives Production by Region (2021-2026)
  5. 3.3.2 Global Artemisinin Derivatives Production by Region (2027-2032)
  6. 3.3.3 Global Artemisinin Derivatives Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Artemisinin Derivatives Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Artemisinin Derivatives Revenue by Region
  3. 4.2.1 Global Artemisinin Derivatives Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Artemisinin Derivatives Revenue by Region (2021-2026)
  5. 4.2.3 Global Artemisinin Derivatives Revenue by Region (2027-2032)
  6. 4.2.4 Global Artemisinin Derivatives Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Artemisinin Derivatives Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Artemisinin Derivatives Sales by Region
  9. 4.4.1 Global Artemisinin Derivatives Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Artemisinin Derivatives Sales by Region (2021-2026)
  11. 4.4.3 Global Artemisinin Derivatives Sales by Region (2027-2032)
  12. 4.4.4 Global Artemisinin Derivatives Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Artemisinin Derivatives Revenue by Manufacturers
  2. 5.1.1 Global Artemisinin Derivatives Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Artemisinin Derivatives Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Artemisinin Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Artemisinin Derivatives Sales by Manufacturers
  6. 5.2.1 Global Artemisinin Derivatives Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Artemisinin Derivatives Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Artemisinin Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Artemisinin Derivatives Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Artemisinin Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Artemisinin Derivatives Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Artemisinin Derivatives Manufacturers, Product Type & Application
  13. 5.7 Global Artemisinin Derivatives Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Artemisinin Derivatives Market CR5 and HHI
  16. 5.8.2 2025 Artemisinin Derivatives Tier 1, Tier 2, and Tier 3
6 Artemisinin Derivatives Market by Type
  1. 6.1 Global Artemisinin Derivatives Revenue by Type
  2. 6.1.1 Global Artemisinin Derivatives Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Artemisinin Derivatives Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Artemisinin Derivatives Sales by Type
  5. 6.2.1 Global Artemisinin Derivatives Sales by Type (2021-2032) & (t)
  6. 6.2.2 Global Artemisinin Derivatives Sales Market Share by Type (2021-2032)
  7. 6.3 Global Artemisinin Derivatives Price by Type
7 Artemisinin Derivatives Market by Application
  1. 7.1 Global Artemisinin Derivatives Revenue by Application
  2. 7.1.1 Global Artemisinin Derivatives Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Artemisinin Derivatives Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Artemisinin Derivatives Sales by Application
  5. 7.2.1 Global Artemisinin Derivatives Sales by Application (2021-2032) & (t)
  6. 7.2.2 Global Artemisinin Derivatives Sales Market Share by Application (2021-2032)
  7. 7.3 Global Artemisinin Derivatives Price by Application
8 Company Profiles
  1. 8.1 Kerui Nanhai Pharmaceutical
  2. 8.1.1 Kerui Nanhai Pharmaceutical Company Information
  3. 8.1.2 Kerui Nanhai Pharmaceutical Business Overview
  4. 8.1.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio
  6. 8.1.5 Kerui Nanhai Pharmaceutical Recent Developments
  7. 8.2 Shanghai Natural Bio-engineering Co
  8. 8.2.1 Shanghai Natural Bio-engineering Co Company Information
  9. 8.2.2 Shanghai Natural Bio-engineering Co Business Overview
  10. 8.2.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio
  12. 8.2.5 Shanghai Natural Bio-engineering Co Recent Developments
  13. 8.3 Shanghai Natural Bio-engineering
  14. 8.3.1 Shanghai Natural Bio-engineering Company Information
  15. 8.3.2 Shanghai Natural Bio-engineering Business Overview
  16. 8.3.3 Shanghai Natural Bio-engineering Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio
  18. 8.3.5 Shanghai Natural Bio-engineering Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Artemisinin Derivatives Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Kunming Pharmaceutical
  26. 8.5.1 Kunming Pharmaceutical Company Information
  27. 8.5.2 Kunming Pharmaceutical Business Overview
  28. 8.5.3 Kunming Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio
  30. 8.5.5 Kunming Pharmaceutical Recent Developments
  31. 8.6 Kerui Nanhai
  32. 8.6.1 Kerui Nanhai Company Information
  33. 8.6.2 Kerui Nanhai Business Overview
  34. 8.6.3 Kerui Nanhai Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Kerui Nanhai Artemisinin Derivatives Product Portfolio
  36. 8.6.5 Kerui Nanhai Recent Developments
  37. 8.7 Guilin Pharmaceutical
  38. 8.7.1 Guilin Pharmaceutical Company Information
  39. 8.7.2 Guilin Pharmaceutical Business Overview
  40. 8.7.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio
  42. 8.7.5 Guilin Pharmaceutical Recent Developments
  43. 8.8 Guangxi Xiancaotang Pharmaceutical
  44. 8.8.1 Guangxi Xiancaotang Pharmaceutical Company Information
  45. 8.8.2 Guangxi Xiancaotang Pharmaceutical Business Overview
  46. 8.8.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio
  48. 8.8.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
  49. 8.9 Guangxi Xiancaotang
  50. 8.9.1 Guangxi Xiancaotang Company Information
  51. 8.9.2 Guangxi Xiancaotang Business Overview
  52. 8.9.3 Guangxi Xiancaotang Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio
  54. 8.9.5 Guangxi Xiancaotang Recent Developments
  55. 8.10 Novanat Bioresource
  56. 8.10.1 Novanat Bioresource Company Information
  57. 8.10.2 Novanat Bioresource Business Overview
  58. 8.10.3 Novanat Bioresource Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Novanat Bioresource Artemisinin Derivatives Product Portfolio
  60. 8.10.5 Novanat Bioresource Recent Developments
  61. 8.11 KPC Pharmaceuticals
  62. 8.11.1 KPC Pharmaceuticals Company Information
  63. 8.11.2 KPC Pharmaceuticals Business Overview
  64. 8.11.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio
  66. 8.11.5 KPC Pharmaceuticals Recent Developments
  67. 8.12 Botanical Extracts EPZ Ltd
  68. 8.12.1 Botanical Extracts EPZ Ltd Company Information
  69. 8.12.2 Botanical Extracts EPZ Ltd Business Overview
  70. 8.12.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio
  72. 8.12.5 Botanical Extracts EPZ Ltd Recent Developments
  73. 8.13 ArtemiFlow
  74. 8.13.1 ArtemiFlow Company Information
  75. 8.13.2 ArtemiFlow Business Overview
  76. 8.13.3 ArtemiFlow Artemisinin Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 ArtemiFlow Artemisinin Derivatives Product Portfolio
  78. 8.13.5 ArtemiFlow Recent Developments
9 North America
  1. 9.1 North America Artemisinin Derivatives Market Size by Type
  2. 9.1.1 North America Artemisinin Derivatives Revenue by Type (2021-2032)
  3. 9.1.2 North America Artemisinin Derivatives Sales by Type (2021-2032)
  4. 9.1.3 North America Artemisinin Derivatives Price by Type (2021-2032)
  5. 9.2 North America Artemisinin Derivatives Market Size by Application
  6. 9.2.1 North America Artemisinin Derivatives Revenue by Application (2021-2032)
  7. 9.2.2 North America Artemisinin Derivatives Sales by Application (2021-2032)
  8. 9.2.3 North America Artemisinin Derivatives Price by Application (2021-2032)
  9. 9.3 North America Artemisinin Derivatives Market Size by Country
  10. 9.3.1 North America Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Artemisinin Derivatives Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Artemisinin Derivatives Market Size by Type
  2. 10.1.1 Europe Artemisinin Derivatives Revenue by Type (2021-2032)
  3. 10.1.2 Europe Artemisinin Derivatives Sales by Type (2021-2032)
  4. 10.1.3 Europe Artemisinin Derivatives Price by Type (2021-2032)
  5. 10.2 Europe Artemisinin Derivatives Market Size by Application
  6. 10.2.1 Europe Artemisinin Derivatives Revenue by Application (2021-2032)
  7. 10.2.2 Europe Artemisinin Derivatives Sales by Application (2021-2032)
  8. 10.2.3 Europe Artemisinin Derivatives Price by Application (2021-2032)
  9. 10.3 Europe Artemisinin Derivatives Market Size by Country
  10. 10.3.1 Europe Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Artemisinin Derivatives Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Artemisinin Derivatives Market Size by Type
  2. 11.1.1 China Artemisinin Derivatives Revenue by Type (2021-2032)
  3. 11.1.2 China Artemisinin Derivatives Sales by Type (2021-2032)
  4. 11.1.3 China Artemisinin Derivatives Price by Type (2021-2032)
  5. 11.2 China Artemisinin Derivatives Market Size by Application
  6. 11.2.1 China Artemisinin Derivatives Revenue by Application (2021-2032)
  7. 11.2.2 China Artemisinin Derivatives Sales by Application (2021-2032)
  8. 11.2.3 China Artemisinin Derivatives Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Artemisinin Derivatives Market Size by Type
  2. 12.1.1 Asia Artemisinin Derivatives Revenue by Type (2021-2032)
  3. 12.1.2 Asia Artemisinin Derivatives Sales by Type (2021-2032)
  4. 12.1.3 Asia Artemisinin Derivatives Price by Type (2021-2032)
  5. 12.2 Asia Artemisinin Derivatives Market Size by Application
  6. 12.2.1 Asia Artemisinin Derivatives Revenue by Application (2021-2032)
  7. 12.2.2 Asia Artemisinin Derivatives Sales by Application (2021-2032)
  8. 12.2.3 Asia Artemisinin Derivatives Price by Application (2021-2032)
  9. 12.3 Asia Artemisinin Derivatives Market Size by Country
  10. 12.3.1 Asia Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Artemisinin Derivatives Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Artemisinin Derivatives Market Size by Type
  2. 13.1.1 SAMEA Artemisinin Derivatives Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Artemisinin Derivatives Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Artemisinin Derivatives Price by Type (2021-2032)
  5. 13.2 SAMEA Artemisinin Derivatives Market Size by Application
  6. 13.2.1 SAMEA Artemisinin Derivatives Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Artemisinin Derivatives Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Artemisinin Derivatives Price by Application (2021-2032)
  9. 13.3 SAMEA Artemisinin Derivatives Market Size by Country
  10. 13.3.1 SAMEA Artemisinin Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Artemisinin Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Artemisinin Derivatives Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Artemisinin Derivatives Value Chain Analysis
  2. 14.1.1 Artemisinin Derivatives Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Artemisinin Derivatives Production Mode & Process
  6. 14.2 Artemisinin Derivatives Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Artemisinin Derivatives Distributors
  9. 14.2.3 Artemisinin Derivatives Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst